The latest releases to the Australian Securities Exchange (ASX) are listed below. News and media releases filed with the ASX are available at News.
Pharmaxis has established a share sale facility to assist holders of unmarketable parcels sell their shares without incurring brokerage costs, and to reduce the Company’s administrative costs associated with maintaining a large number of shareholders with Unmarketable Parcels.
The facility has been established for holders of parcels of Pharmaxis shares with a market value of less than A$500 (an unmarketable parcel) as at close of trade on 19 February 2016. Based on the Pharmaxis share price of $0.30 at close of trade on 19 February, an unmarketable parcel is a holding of 1,666 (or less) Pharmaxis shares.
If a holder of an unmarketable parcel wishes to have their Pharmaxis shares sold through this facility, they do not need to take any action.
If a holder of an unmarketable parcel wishes to retain their shares, they must complete and return the Share Retention Form that will be posted to them, to the Pharmaxis’ share registry, Computershare Investor Services Pty Limited, by 5:00 pm (Sydney time) on 8 April 2016. Upon the sale of the unmarketable parcels by the appointed broker, proceeds will be forwarded to eligible shareholders as soon as practicable.Read full ASX announcement – pdf